Candel Therapeutics to Participate in Upcoming B. Riley Oncology Conference

January 12, 2023

https://www.globenewswire.com/news-release/2023/01/12/2587826/0/en/Candel-Therapeutics-to-Participate-in-Upcoming-B-Riley-Oncology-Conference.html

NEEDHAM, Mass., Jan. 12, 2023 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Nasdaq:CADL), a clinical stage biopharmaceutical company developing novel viral immunotherapies, today announced that Paul Peter Tak, MD, PhD, FMedSci, President and Chief Executive Officer, will participate in a virtual fireside chat at B. Riley Securities’ 3rd Annual Oncology Conference. Details are as follows:

Read more at globenewswire.com

Related news for (CADL)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.